Cargando…
Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis
BACKGROUND: Preeclampsia (PE) is a new-onset pregnancy-specific disorder with a high prevalence that leads to over 70 000 maternal and 500 000 foetal fatalities worldwide each year. The level of chemerin, a newly identified adipokine, is increased in diabetic and obese patients. Currently, there are...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588206/ https://www.ncbi.nlm.nih.gov/pubmed/37864182 http://dx.doi.org/10.1186/s12944-023-01941-w |
_version_ | 1785123531676188672 |
---|---|
author | Yin, Yangxue Xie, Shuangshuang Xu, Qin Liao, Lingyun Chen, Hongqin Zhou, Rong |
author_facet | Yin, Yangxue Xie, Shuangshuang Xu, Qin Liao, Lingyun Chen, Hongqin Zhou, Rong |
author_sort | Yin, Yangxue |
collection | PubMed |
description | BACKGROUND: Preeclampsia (PE) is a new-onset pregnancy-specific disorder with a high prevalence that leads to over 70 000 maternal and 500 000 foetal fatalities worldwide each year. The level of chemerin, a newly identified adipokine, is increased in diabetic and obese patients. Currently, there are several studies describing the relationship between maternal circulating chemerin levels and PE. Therefore, this study aimed to assess their association in pooled samples. METHODS: Four databases were systematically searched to identify potential studies that reported circulating chemerin levels in PE and normal pregnancy groups. Standardized mean differences (SMDs), 95% confidence intervals (CIs), and 95% prediction intervals (PIs) were calculated using a random-effects meta-analysis. The probability of heterogeneity was also investigated by sensitivity analysis, subgroup analysis, and meta-regression. RESULTS: Thirteen studies in 11 articles with a total of 860 PE patients and 1309 women with normal pregnancies met the inclusion criteria. The results of the meta-analysis revealed that circulating chemerin, which levels in PE patients were considerably higher than those in controls (SMD = 1.39, 95% CI: 1.02, 1.77, 95% PI: -0.07, 2.86). Moreover, sensitivity analysis determined that the outcomes of the overall pooled results were not affected after the elimination of any study. Notably, subgroup analysis demonstrated a similar expression pattern irrespective of geographic location, severity, timing of sampling, and sample size. Last, there were no factors that significantly impacted the overall estimate, according to meta-regression. CONCLUSIONS: This meta-analysis is the first to assess circulating chemerin levels in PE patients. The findings indicate that circulating chemerin levels may be a potential marker to diagnose PE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01941-w. |
format | Online Article Text |
id | pubmed-10588206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105882062023-10-21 Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis Yin, Yangxue Xie, Shuangshuang Xu, Qin Liao, Lingyun Chen, Hongqin Zhou, Rong Lipids Health Dis Research BACKGROUND: Preeclampsia (PE) is a new-onset pregnancy-specific disorder with a high prevalence that leads to over 70 000 maternal and 500 000 foetal fatalities worldwide each year. The level of chemerin, a newly identified adipokine, is increased in diabetic and obese patients. Currently, there are several studies describing the relationship between maternal circulating chemerin levels and PE. Therefore, this study aimed to assess their association in pooled samples. METHODS: Four databases were systematically searched to identify potential studies that reported circulating chemerin levels in PE and normal pregnancy groups. Standardized mean differences (SMDs), 95% confidence intervals (CIs), and 95% prediction intervals (PIs) were calculated using a random-effects meta-analysis. The probability of heterogeneity was also investigated by sensitivity analysis, subgroup analysis, and meta-regression. RESULTS: Thirteen studies in 11 articles with a total of 860 PE patients and 1309 women with normal pregnancies met the inclusion criteria. The results of the meta-analysis revealed that circulating chemerin, which levels in PE patients were considerably higher than those in controls (SMD = 1.39, 95% CI: 1.02, 1.77, 95% PI: -0.07, 2.86). Moreover, sensitivity analysis determined that the outcomes of the overall pooled results were not affected after the elimination of any study. Notably, subgroup analysis demonstrated a similar expression pattern irrespective of geographic location, severity, timing of sampling, and sample size. Last, there were no factors that significantly impacted the overall estimate, according to meta-regression. CONCLUSIONS: This meta-analysis is the first to assess circulating chemerin levels in PE patients. The findings indicate that circulating chemerin levels may be a potential marker to diagnose PE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01941-w. BioMed Central 2023-10-20 /pmc/articles/PMC10588206/ /pubmed/37864182 http://dx.doi.org/10.1186/s12944-023-01941-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yin, Yangxue Xie, Shuangshuang Xu, Qin Liao, Lingyun Chen, Hongqin Zhou, Rong Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis |
title | Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis |
title_full | Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis |
title_fullStr | Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis |
title_full_unstemmed | Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis |
title_short | Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis |
title_sort | circulating chemerin levels in preeclampsia: a systematic review and meta-analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588206/ https://www.ncbi.nlm.nih.gov/pubmed/37864182 http://dx.doi.org/10.1186/s12944-023-01941-w |
work_keys_str_mv | AT yinyangxue circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis AT xieshuangshuang circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis AT xuqin circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis AT liaolingyun circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis AT chenhongqin circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis AT zhourong circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis |